Drug Reduction Intervention for Needle Exchange Clients
针交换客户的药物减少干预
基本信息
- 批准号:6800555
- 负责人:
- 金额:$ 39.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-25 至 2007-08-31
- 项目状态:已结题
- 来源:
- 关键词:HIV infectionsadult human (21+)behavior therapyclinical researchcost effectivenessdisease /disorder proneness /riskdrug abuse therapyhuman subjecthuman therapy evaluationinjection /infusioninterviewlongitudinal human studymotivationneedle sharingoutcomes researchplacebossubstance abuse related behavior
项目摘要
DESCRIPTION: (Applicant's Abstract)
Injection drug users are at risk for a variety of problems such as HIV
infection, hepatitis B and C, endocarditis, trauma, legal and work difficulties
and family dysfunction. The objective of this research is to investigate ways
to effectively reduce drug use among needle exchange program users, whose
attendance at such services may signal the beginnings of risk reduction and a
desire to escape drug use. In the past two decades brief interventions have
proven to be promising in reducing substance abuse in a variety of settings.
Recent developments in treatments for substance abuse underscore the primacy of
utilizing motivation-based approaches. However, few studies have examined the
likelihood that using a brief motivation based intervention with drug users
enrolled in needle exchange programs may improve drug use outcomes.
Intensifying brief intervention by adding a booster session might further
enhance efficacy.
The long-term objective of this programmatic body of treatment outcome research
is to provide effective brief interventions for adult substance abusers. The
specific aims of this proposal are to investigate the extent to which a
Motivational Interview with a booster session is effective in reducing drug use
among injection drug users enrolled in needle exchange programs as compared to
an Attention Placebo Control (AQ condition in a 2-group design. Patients will
be followed at 1-and 6 months after the baseline intervention, with
self-reports confirmed by urine screens and reports of family or friends.
Primary outcome variables include total number of drug use days and number of
days in treatment. It is hypothesized that groups receiving MI will show lower
levels of drug using days and more days of substance abuse treatment and that
2) the relationship between MI and the outcome variables will vary as a
function of the patient's degree of readiness to change.
This study will extend previous research by evaluating the use of MI with
individuals who are needle exchange participants. The development of effective
interventions for a population with poor linkage to primary care, an enormous
burden of illness, and high HIV transmission risk should reduce the chronicity
of drug use and enhance days in drug treatment.
描述:(申请人的摘要)
注射吸毒者面临诸如艾滋病毒等各种问题的风险
感染,乙型肝炎和C,心内膜炎,创伤,法律和工作困难
和家庭功能障碍。这项研究的目的是调查方法
有效地减少针头交换计划使用者的药物使用,他们
参加此类服务的出席可能标志着降低风险的开始和
渴望逃避吸毒。在过去的二十年中,简短干预措施有
事实证明,在各种环境中减少药物滥用方面是有希望的。
滥用药物治疗的最新发展强调了
利用基于动力的方法。但是,很少有研究检查
与吸毒者使用基于动机的简短干预的可能性
参加针头交换计划可以改善药物使用结果。
通过添加助推器会议来加强简短的干预可能会进一步
增强功效。
这项程序化治疗结果研究的长期目标
是为成人滥用者提供有效的简短干预措施。这
该提案的具体目的是调查一定程度的程度
通过助推器会议的励志访谈有效减少吸毒
在注册吸毒者中,与
注意安慰剂控制(2组设计中的AQ条件。患者将
在基线干预后的1和6个月紧随其后,
尿液屏幕和家人或朋友的报告证实了自我报告。
主要结果变量包括吸毒天数和数量
治疗的天数。假设接收MI的组将显示较低
使用天数和更多天的药物滥用治疗的药物水平,并且
2)MI和结果变量之间的关系将随着一个
患者准备改变程度的功能。
这项研究将通过评估MI的使用与
是针交换参与者的个人。有效的发展
与初级保健联系不佳的人群的干预措施,这是巨大的
疾病负担和高艾滋病毒传播风险应减少慢性
药物使用和增强药物治疗的天数。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert Swift其他文献
Robert Swift的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert Swift', 18)}}的其他基金
Crossover Study of an Oral Treatment for Sickle Cell Disease
镰状细胞病口服治疗的交叉研究
- 批准号:
9347994 - 财政年份:2017
- 资助金额:
$ 39.25万 - 项目类别:
Identification of the Antisickling Compounds in SCD-101
SCD-101 中抗镰化化合物的鉴定
- 批准号:
9407759 - 财政年份:2017
- 资助金额:
$ 39.25万 - 项目类别:
Elucidation of Antisickling Molecules in a Botanical with Antisickling Activity
具有抗镰刀活性的植物中抗镰刀分子的阐明
- 批准号:
8589491 - 财政年份:2013
- 资助金额:
$ 39.25万 - 项目类别:
First Clinical Trial of an Anti-Sickling Botanical Drug for Sickle Cell Dise
抗镰状细胞病植物药物的首次临床试验
- 批准号:
8529844 - 财政年份:2013
- 资助金额:
$ 39.25万 - 项目类别:
Safety Studies for Clinical Trials of a Botanical Drug for Sickle Cell Disease
镰状细胞病植物药临床试验的安全性研究
- 批准号:
9052235 - 财政年份:2013
- 资助金额:
$ 39.25万 - 项目类别:
Safety Studies for Clinical Trials of a Botanical Drug for Sickle Cell Disease
镰状细胞病植物药临床试验的安全性研究
- 批准号:
9335417 - 财政年份:2013
- 资助金额:
$ 39.25万 - 项目类别:
Toxicity Studies of Potent Antisickling Agent 5HMF
强效抗镰刀剂5HMF的毒性研究
- 批准号:
7108317 - 财政年份:2006
- 资助金额:
$ 39.25万 - 项目类别:
相似海外基金
Integration of Trusted Adult Supports into the HealthMpowerment App to Improve Black Adolescent and Young Adult PrEP Use
将值得信赖的成人支持整合到 HealthMpowerment 应用程序中,以改善黑人青少年和年轻成人 PrEP 的使用
- 批准号:
10483485 - 财政年份:2022
- 资助金额:
$ 39.25万 - 项目类别:
Integration of Trusted Adult Supports into the HealthMpowerment App to Improve Black Adolescent and Young Adult PrEP Use
将值得信赖的成人支持整合到 HealthMpowerment 应用程序中,以改善黑人青少年和年轻成人 PrEP 的使用
- 批准号:
10610486 - 财政年份:2022
- 资助金额:
$ 39.25万 - 项目类别:
Physician Attitudes toward New Biomedical HIV Prevention Interventions in Youth
医生对青年新的生物医学艾滋病毒预防干预措施的态度
- 批准号:
9335414 - 财政年份:2013
- 资助金额:
$ 39.25万 - 项目类别: